Skip to main content
Top
Published in: Journal of Cancer Education 6/2018

01-12-2018

Adherence in the Cancer Care Setting: a Systematic Review of Patient Navigation to Traverse Barriers

Authors: Matthew L. Bush, Michael R. Kaufman, Taylor Shackleford

Published in: Journal of Cancer Education | Issue 6/2018

Login to get access

Abstract

Patient navigation is an evidence-based intervention involving trained healthcare workers who assist patients in assessing and mitigating personal and environmental factors to promote healthy behaviors. The purpose of this research is to systematically assess the efficacy of patient navigation and similar programs to improve diagnosis and treatment of diseases affecting medically underserved populations. A systematic review was performed by searching PubMed, MEDLINE, PsychINFO, and CINAHL to identify potential studies. Eligible studies were those containing original peer-reviewed research reports in English on patient navigation, community health workers, vulnerable and underserved populations, and healthcare disparity. Specific outcomes regarding patient navigator including the effect of the intervention on definitive diagnosis and effect on initiation of treatment were extracted from each study. The search produced 1428 articles, and 16 were included for review. All studies involved patient navigation in the field of oncology in underserved populations. Timing of initial contact with a patient navigator after diagnostic or screening testing is correlated to the effectiveness of the navigator intervention. The majority of the studies reported significantly shorter time intervals to diagnosis and to treatment with patient navigation. Patient navigation expedites oncologic diagnosis and treatment of patients in underserved populations. This intervention is more efficacious when utilized shortly after screening or diagnostic testing.
Literature
1.
go back to reference Martin LR, Williams SL, Haskard KB, DiMatteo MR (2005) The challenge of patient adherence. Ther Clin Risk Manag 1(3):189–199PubMedPubMedCentral Martin LR, Williams SL, Haskard KB, DiMatteo MR (2005) The challenge of patient adherence. Ther Clin Risk Manag 1(3):189–199PubMedPubMedCentral
2.
go back to reference Ferrante JM, Chen P, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. Journal of Urban Health: Bulletin of the New York Academy of Medicine 85(1):114–124. doi:10.1007/s11524-007-9228-9 CrossRef Ferrante JM, Chen P, Kim S (2008) The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. Journal of Urban Health: Bulletin of the New York Academy of Medicine 85(1):114–124. doi:10.​1007/​s11524-007-9228-9 CrossRef
3.
go back to reference Battaglia TA, Bak S, Heeren T et al (2012) Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomark Prev 21(10):1645–1654. doi:10.1158/1055- 9965.EPI-12-0532 CrossRef Battaglia TA, Bak S, Heeren T et al (2012) Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomark Prev 21(10):1645–1654. doi:10.​1158/​1055- 9965.​EPI-12-0532 CrossRef
5.
go back to reference Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. Br Med J 338:b2535CrossRef Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. Br Med J 338:b2535CrossRef
6.
go back to reference Oxford Centre for Evidence-based Medicine—levels of evidence (2009). Centre for Evidence-Based Medicine. Retrieved May 4, 2016 Oxford Centre for Evidence-based Medicine—levels of evidence (2009). Centre for Evidence-Based Medicine. Retrieved May 4, 2016
7.
go back to reference Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ (2015) Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Women’s Health 24(2):138–143. doi:10.1089/jwh.2014.4954 CrossRef Percac-Lima S, Ashburner JM, McCarthy AM, Piawah S, Atlas SJ (2015) Patient navigation to improve follow-up of abnormal mammograms among disadvantaged women. J Women’s Health 24(2):138–143. doi:10.​1089/​jwh.​2014.​4954 CrossRef
8.
go back to reference Lee J, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R (2014) Effect of patient navigation on time to diagnostic resolution among patients with colorectal cancer-related abnormalities. J Canc Educ 29:144–150. doi:10.1007/s13187-013-0561-2 CrossRef Lee J, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R (2014) Effect of patient navigation on time to diagnostic resolution among patients with colorectal cancer-related abnormalities. J Canc Educ 29:144–150. doi:10.​1007/​s13187-013-0561-2 CrossRef
9.
go back to reference Freund KM, Battaglia TA, Calhoun E et al (2014) Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. JNCI 106(6). doi:10.1093/jnci/dju115 Freund KM, Battaglia TA, Calhoun E et al (2014) Impact of patient navigation on timely cancer care: the Patient Navigation Research Program. JNCI 106(6). doi:10.​1093/​jnci/​dju115
10.
go back to reference Bensink ME, Ramsey SD, Battaglia T et al (2014) Costs and outcomes evaluation of patient navigation after abnormal cancer screening. Cancer:570–578. doi:10.1002/cncr.28438 Bensink ME, Ramsey SD, Battaglia T et al (2014) Costs and outcomes evaluation of patient navigation after abnormal cancer screening. Cancer:570–578. doi:10.​1002/​cncr.​28438
11.
go back to reference Lee J, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R (2013) Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL. PLoS One 8(9):e74542. doi:10.1371/journal.pone.0074542 CrossRefPubMedPubMedCentral Lee J, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R (2013) Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL. PLoS One 8(9):e74542. doi:10.​1371/​journal.​pone.​0074542 CrossRefPubMedPubMedCentral
12.
go back to reference Dudley DJ, Drake J, Quinlan J et al (2012) Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomark Prev 21(10):1639–1644. doi:10.1158/1055- 9965.EPI-12-0538 CrossRef Dudley DJ, Drake J, Quinlan J et al (2012) Beneficial effects of a combined navigator/promotora approach for Hispanic women diagnosed with breast abnormalities. Cancer Epidemiol Biomark Prev 21(10):1639–1644. doi:10.​1158/​1055- 9965.​EPI-12-0538 CrossRef
13.
go back to reference Markossian TW, Darnell JS, Calhoun EA (2012) Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomark Prev 21(10):1691–1700. doi:10.1158/1055- 9965.EPI-12-0535 CrossRef Markossian TW, Darnell JS, Calhoun EA (2012) Follow-up and timeliness after an abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol Biomark Prev 21(10):1691–1700. doi:10.​1158/​1055- 9965.​EPI-12-0535 CrossRef
14.
go back to reference Paskett E, Katz ML, Douglas MP et al (2012) The ohio Patient Navigation Research Program (OPNRP): does the American Cancer Society patient navigation model improve time to resolution among patients with abnormal screening tests? Cancer Epidemiol Biomark Prev 21(10):1620–1628. doi:10.1158/1055-9965.EPI-12-0523 CrossRef Paskett E, Katz ML, Douglas MP et al (2012) The ohio Patient Navigation Research Program (OPNRP): does the American Cancer Society patient navigation model improve time to resolution among patients with abnormal screening tests? Cancer Epidemiol Biomark Prev 21(10):1620–1628. doi:10.​1158/​1055-9965.​EPI-12-0523 CrossRef
15.
go back to reference Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D (2012) Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomark Prev 21(10):1629–1638. doi:10.1158/1055-9965.EPI-12-0513 CrossRef Raich PC, Whitley EM, Thorland W, Valverde P, Fairclough D (2012) Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol Biomark Prev 21(10):1629–1638. doi:10.​1158/​1055-9965.​EPI-12-0513 CrossRef
16.
go back to reference Wells KJ, Lee J, Calcano E et al (2012) A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomark Prev 21(10):1664–1672. doi:10.1158/1055-9965.EPI-12-0448 CrossRef Wells KJ, Lee J, Calcano E et al (2012) A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiol Biomark Prev 21(10):1664–1672. doi:10.​1158/​1055-9965.​EPI-12-0448 CrossRef
18.
go back to reference Ell K, Vourlekis B, Muderspach L et al (2002) Abnormal cervical screen follow-up among low-income Latinas: project safe. J Women’s Health Gend-Based Med 11(7):639–651CrossRef Ell K, Vourlekis B, Muderspach L et al (2002) Abnormal cervical screen follow-up among low-income Latinas: project safe. J Women’s Health Gend-Based Med 11(7):639–651CrossRef
19.
go back to reference Ramirez A, Perez-Stable E, Penedo F et al (2014) Reducing time-to-treatment in underserved Latinas with breast cancer. Cancer:752–760. doi:10.1002/cncr.28450 Ramirez A, Perez-Stable E, Penedo F et al (2014) Reducing time-to-treatment in underserved Latinas with breast cancer. Cancer:752–760. doi:10.​1002/​cncr.​28450
20.
go back to reference Ell K, Padgett D, Vourlekis B et al (2002) Abnormal mammogram follow-up: a pilot study in women with low income. Cancer Pract 10(3):130–138CrossRefPubMed Ell K, Padgett D, Vourlekis B et al (2002) Abnormal mammogram follow-up: a pilot study in women with low income. Cancer Pract 10(3):130–138CrossRefPubMed
23.
24.
go back to reference Gilbert JE, Green E, Lankshear S et al (2011) Nurses as patient navigators in cancer diagnosis: review, consultation and model design. Eur J Cancer Care 20:228–236CrossRef Gilbert JE, Green E, Lankshear S et al (2011) Nurses as patient navigators in cancer diagnosis: review, consultation and model design. Eur J Cancer Care 20:228–236CrossRef
Metadata
Title
Adherence in the Cancer Care Setting: a Systematic Review of Patient Navigation to Traverse Barriers
Authors
Matthew L. Bush
Michael R. Kaufman
Taylor Shackleford
Publication date
01-12-2018
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 6/2018
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1235-2

Other articles of this Issue 6/2018

Journal of Cancer Education 6/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine